Randomized controlled trial of primary prevention of atopy using house dust mite allergen oral immunotherapy in early childhood

Journal of Allergy and Clinical Immunology

Volumn 136, Issue 6, 2015, Pages 1541-1547.e11

  Zolkipli, Zaraquiza ^a   Roberts, Graham ^a,b,c   Cornelius, Victoria ^a,d   Clayton, Bernie ^c   Pearson, Sarah ^a   Michaelis, Louise ^a   Djukanovic, Ratko ^a,b   Kurukulaaratchy, Ramesh ^a,b,c   Arshad, S Hasan ^a,b,c  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

allergen; Atopy; early childhood; house dust mite; infant; oral immunotherapy; primary prevention; randomized controlled trial

Indexed keywords

HOUSE DUST ALLERGEN; PLACEBO; ALLERGEN;

ARTICLE; ATOPY; CHILDHOOD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; DRUG TOLERABILITY; ECZEMA; FEMALE; FOOD ALLERGY; HIGH RISK PATIENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; ORAL IMMUNOTHERAPY; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PRICK TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SENSITIZATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WHEEZING; ADVERSE EFFECTS; ANIMAL; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; HYPERSENSITIVITY; IMMUNOLOGY; IMMUNOTHERAPY; ORAL DRUG ADMINISTRATION; PRIMARY PREVENTION;

ADMINISTRATION, ORAL; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; INFANT; MALE; PRIMARY PREVENTION;

EID: 84947962151     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.04.045     Document Type: Article

References (37)

1. Asthma facts and FAQs. Available at: http://www.asthma.org.uk/asthma-facts-and-statistics. Accessed November 9, 2014.
2. L.J. Akinbami, J.E. Moorman, C. Bailey, H.C. Zahran, M. King, C.A. Johnson, and et al. Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010 NCHS Data Brief 94 2012 1 8
3. S. Krauss-Etschmann, A. Bush, S. Bellusci, G.G. Brusselle, S.E. Dahlén, S. Dehmel, and et al. Of flies, mice and men: a systematic approach to understanding the early life origins of chronic lung disease Thorax 68 2013 380 384
4. S.H. Arshad, S. Matthews, C. Gant, and D.W. Hide Effect of allergen avoidance on development of allergic disorders in infancy Lancet 339 1992 1493 1497
5. S.H. Arshad, B. Bateman, and S.M. Matthews Primary prevention of asthma and atopy during childhood by allergen avoidance in infancy: a randomised controlled study Thorax 58 2003 489 493
6. M. Scott, G. Roberts, R.J. Kurukulaaratchy, S. Matthews, A. Nove, and S.H. Arshad Multifaceted allergen avoidance during infancy reduces asthma during childhood with the effect persisting until age 18 years Thorax 67 2012 1046 1051
7. U. Haddeland, A.B. Karstensen, L. Farkas, K.O. Bø, J. Pirhonen, M. Karlsson, and et al. Putative regulatory T cells are impaired in cord blood from neonates with hereditary allergy risk Pediatr Allergy Immunol 16 2005 104 112
8. S.Z. Josefowicz, L.F. Lu, and A.Y. Rudensky Regulatory T cells: mechanisms of differentiation and function Annu Rev Immunol 30 2012 531 564
9. H. Grindebacke, H. Stenstad, M. Quiding-Jarbrink, J. Waldenström, I. Adlerberth, A.E. Wold, and et al. Dynamic development of homing receptor expression and memory cell differentiation of infant CD4+CD25high regulatory T cells J Immunol 183 2009 4360 4370
10. H. Mosbech Tolerability and efficacy of house dust mite AIT Allergy 66 suppl 95 2011 55 56
11. Piantadosi A. Sample size and power. Clinical trials: a methodologic perspective. London: Wiley; 2005.
12. D.W. Hide, S. Matthews, L. Matthews, M. Stevens, S. Ridout, R. Twiselton, and et al. Effect of allergen avoidance in infancy on allergic manifestations at age two years J Allergy Clin Immunol 93 1994 842 846
13. S. Greenland, and P. Holland Estimating standardized risk differences from odds ratios Biometrics 47 1991 319 322
14. S.M. Tariq, S.M. Matthews, E.A. Hakim, and S.H. Arshad Egg allergy in infancy predicts respiratory allergic disease by 4 years of age Pediatr Allergy Immunol 11 2000 162 167
15. S.H. Arshad, B. Bateman, A. Sadeghnejad, C. Gant, and S.M. Matthews Prevention of allergic disease during childhood by allergen avoidance: the Isle of Wight prevention study J Allergy Clin Immunol 119 2007 307 313
16. N. Lazic, G. Roberts, A. Custovic, D. Belgrave, C.M. Bishop, J. Winn, and et al. Multiple atopy phenotypes and their associations with asthma: similar findings from two birth cohorts Allergy 68 2013 764 770
17. L.G. Gregory, and C.M. Lloyd Orchestrating house dust mite-associated allergy in the lung Trends Immunol 32 2011 402 411
18. M.A. Calderón, A. Linneberg, J. Kleine-Tebbe, F. De Blay, D. Hernandez Fernandez de Rojas, J.C. Virchow, and et al. Respiratory allergy caused by house dust mites: what do we really know? J Allergy Clin Immunol 136 2015 38 48
19. T. Dean, C. Venter, B. Pereira, S.H. Arshad, J. Grundy, C.B. Clayton, and et al. Patterns of sensitization to food and aeroallergens in the first 3 years of life J Allergy Clin Immunol 120 2007 1166 1171
20. A. Muraro, S. Halken, S.H. Arshad, K. Beyer, A.E. Dubois, G. Du Toit, and et al. EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy Allergy 69 2014 590 601
21. G. Du Toit, Y. Katz, P. Sasieni, D. Mesher, S.J. Maleki, H.R. Fisher, and et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy J Allergy Clin Immunol 122 2008 984 991
22. G. Du Toit, G. Roberts, P.H. Sayre, H.T. Bahnson, S. Radulovic, A.F. Santos, and et al. Randomized trial of peanut consumption in infants at risk for peanut allergy N Engl J Med 372 2015 803 813
23. M.N. Sato, A.F. Carvalho, A.O. Silva, M. MacIel Jr., A.E. Fusaro, and A.J. Duarte Oral tolerance induced to house dust mite extract in naive and sensitized mice: evaluation of immunoglobulin G anti-immunoglobulin E autoantibodies and IgG-IgE complexes Immunology 95 1998 193 199
24. C. Rask, J. Brimnes, S. Urioste, and K. Lund Prophylactic sublingual treatment with high dose Der f extract prevents the development of house dust mite induced allergic asthma in naïve, non-sensitized mice J Allergy Clin Immunol 125 Suppl 1 2010 AB1-AB360
25. P.G. Holt, P.D. Sly, H.A. Sampson, P. Robinson, R. Loh, H. Lowenstein, and et al. Prophylactic use of sublingual allergen immunotherapy in high-risk children: a pilot study J Allergy Clin Immunol 132 2013 991 993.e1
26. P.G. Holt, J. Rowe, M. Kusel, F. Parsons, E.M. Hollams, A. Bosco, and et al. Toward improved prediction of risk for atopy and asthma among preschoolers: a prospective cohort study J Allergy Clin Immunol 125 2010 653 659 e1-9
27. A.M. Schoos, B.L. Chawes, N. Folsgaard, N. Samandari, K. Bonnelykke, and H. Bisgaard Disagreement between skin prick test and specific IgE in young children Allergy 70 2015 41 48
28. V. Niederberger, P. Stubner, S. Spitzauer, D. Kraft, R. Valenta, K. Ehrenberger, and et al. Skin test results but not serology reflect immediate type respiratory sensitivity: a study performed with recombinant allergen molecules J Invest Dermatol 117 2001 848 851
29. S.R. Durham, S.M. Walker, E.M. Varga, M.R. Jacobson, F. O'Brien, W. Noble, and et al. Long-term clinical efficacy of grass-pollen immunotherapy N Engl J Med 341 1999 468 475
30. J. Bousquet, R. Lockey, and H.J. Malling Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper J Allergy Clin Immunol 102 1998 558 562
31. G.B. Pajno, G. Barberio, F. De Luca, L. Morabito, and S. Parmiani Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study Clin Exp Allergy 31 2001 1392 1397
32. L. Jacobsen, B. Niggemann, S. Dreborg, H.A. Ferdousi, S. Halken, A. Høst, and et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study Allergy 62 2007 943 948
33. J.N. Francis, S.J. Till, and S.R. Durham Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy J Allergy Clin Immunol 111 2003 1255 1261
34. A. Bufe, and G. Roberts Specific immunotherapy in children Clin Exp Allergy 41 2011 1256 1262
35. M. Penagos, E. Compalati, F. Tarantini, R. Baena-Cagnani, J. Huerta, G. Passalacqua, and et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials Ann Allergy Asthma Immunol 97 2006 141 148
36. S.H. Arshad, R.J. Kurukulaaratchy, M. Fenn, and S. Matthews Early life risk factors for current wheeze, asthma, and bronchial hyperresponsiveness at 10 years of age Chest 127 2005 502 508
37. A.C. Wu, M.G. Butler, L. Li, V. Fung, E.O. Kharbanda, E.K. Larkin, and et al. Primary adherence to controller medications for asthma is poor Ann Am Thorac Soc 12 2015 161 166